Rethinking Global Access to Vaccines

Chokshi DA, Kesselheim AS - BMJ

  • Price, Value, and Access

Summary:

The authors challenge three common arguments used to explain inadequate vaccine access in low-income countries—the primacy of infrastructure, insufficient funding, and the need for prior approval in wealthy nations—arguing that each can be overcome with targeted policy interventions. They contend that vaccination programs can themselves strengthen health infrastructure and that mechanisms like advance market commitments and tiered pricing can address funding and access gaps.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty

Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open

  • Price, Value, and Access